ASCO: Melanoma Tx Turns in 'Striking' Results

CHICAGO (MedPage Today) -- An investigational immune therapy, lambrolizumab, was safe and well tolerated in patients with advanced melanoma, a researcher reported here. via MedPageToday.com - medical news plus CME for physicians Read More Here..